Crescent Capital BDC (NASDAQ:CCAP) Price Target Raised to $20.00

Crescent Capital BDC (NASDAQ:CCAP) had its target price hoisted by Keefe, Bruyette & Woods from $19.00 to $20.00 in a research note released on Monday,Benzinga reports. The firm currently has an outperform rating on the stock.

A number of other equities analysts have also commented on CCAP. Wells Fargo & Company cut their price objective on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 14th. LADENBURG THALM/SH SH initiated coverage on Crescent Capital BDC in a research report on Monday, September 30th. They set a “buy” rating and a $20.00 target price on the stock. Finally, Bank of America reduced their price target on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 15th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $19.17.

Crescent Capital BDC Trading Up 0.1 %

CCAP opened at $19.29 on Monday. The firm’s 50 day moving average is $18.57 and its 200-day moving average is $18.51. Crescent Capital BDC has a 52-week low of $15.91 and a 52-week high of $19.63. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.14. The firm has a market capitalization of $714.89 million, a P/E ratio of 7.56 and a beta of 0.81.

Crescent Capital BDC Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st will be paid a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.71%. The ex-dividend date is Tuesday, December 31st. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s dividend payout ratio is 65.88%.

Hedge Funds Weigh In On Crescent Capital BDC

A number of hedge funds have recently bought and sold shares of CCAP. HighTower Advisors LLC lifted its holdings in Crescent Capital BDC by 0.5% during the 3rd quarter. HighTower Advisors LLC now owns 141,838 shares of the company’s stock worth $2,624,000 after buying an additional 768 shares during the last quarter. Confluence Investment Management LLC lifted its stake in Crescent Capital BDC by 2.2% during the third quarter. Confluence Investment Management LLC now owns 73,206 shares of the company’s stock worth $1,354,000 after purchasing an additional 1,583 shares during the last quarter. Point72 Asset Management L.P. acquired a new position in Crescent Capital BDC in the second quarter worth $90,000. Sumitomo Mitsui Trust Holdings Inc. increased its stake in Crescent Capital BDC by 14.1% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 80,766 shares of the company’s stock valued at $1,517,000 after purchasing an additional 10,000 shares during the last quarter. Finally, XTX Topco Ltd acquired a new stake in shares of Crescent Capital BDC during the second quarter worth $195,000. 49.46% of the stock is currently owned by institutional investors and hedge funds.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.